
Immune Cell Therapy Cuts Cirrhosis Death Risk in Trial
A new treatment using specially prepared immune cells has helped people with cirrhosis avoid liver transplants and live longer. The infusions of modified macrophages mark a potential breakthrough for the 2 million Americans living with this life-threatening liver disease.
















